The Correlation Between Depression Symptoms and Length of Disease in Scleroderma Patients. Eva Rajan

Transcription

1 The Correlation Between Depression Symptoms and Length of Disease in Scleroderma Patients Eva Rajan

2 Introduction characterized by the thickening of the connective tissue and internal organs 2 types of Scleroderma: Limited Systemic Sclerosis Patients can live with limited Systemic Sclerosis patients on average live 3-5 years after diagnosis

3 Review of Literature Societal impact is great high rates of disability and shortened life expectancy (Medsger 1997) Burn victims and scleroderma: body image dissatisfaction (Benrud-Larson 2002) Scleroderma patients with more skin thickening had lower appearance self esteem linked to more psychological distress. (Melcarne et al., 1999)

4 Review of Literature Relationship between body image Psychological distress as well as adaptation to illness and depression Researchers get their information based on: interactions with medical staff their general beliefs about health and illness information from friends and family internet

5 Review of Literature Heinberg (2005) researchers found that if they had a chance to die they would take it. Depression is an aspect that is often overlooked.

6 Hypothesis/Research Objectives Research Objectives: To see if there is an association between length of disease and depression in scleroderma patients. Hypothesis: Length of disease is likely to affect depression among scleroderma patients

7 Subjects - Demographics 186 scleroderma patients subscribed to the weekly e-letter. 13 men 173 women From the United States, Australia, Great Britain, and Canada. All subjects had scleroderma. All subjects were over the age of 18 years.

8 Subject Recruitment/Selection 9,000 patients receive the weekly e-letter. Main story for one week Side story for 3 weeks Link gave basic information History of certain medical conditions can affect the answers. General Demographics Questionnaire Taken prior to the actual survey to screen out patients.

9 Procedure Survey on Scleroderma Foundation e-letter Self-Consent Anonymous Submission by &ft=1&f=1027,1030,1066

10 Instruments Center for Epidemiologic Studies Depression Scale (CES- D) 20 questions Self-Administered Measures depressive symptoms Sleep disturbance Loss of appetite Feelings of worthlessness Guilt Takes 5 minutes (Radloff, 1977; Comstock & Helsing, 1976; Weissman, Shlomoskas, Pottenger, Prusoff)

11 Sample Questions From CES-D Survey I did not feel like eating; my appetite was poor. I felt depressed. I thought my life had been a failure. I felt fearful. People were unfriendly. I felt that people dislike me.

12 Results Sample: % females 7.5% males. Total mean score or the overall average on the CES-D scale was 18.9 (12.7).

13 Conclusions Women get older, less depressed Low scores on CES-D grew older lower levels of depression. Males felt they were just as good as other people more often than females Males had more occasions of restless sleep than females

14 References 1. Angelopoulos NV, Drosos AA, Moutsopoulos HM. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001;70: Benrud-Larson, L. M., Haythornthwaite, J. A., Heinberg, L. J., Boling, C., Reed, J., White, B., et al. (2002). The impact of pain and symptoms of depression in scleroderma. Pain, 95, Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo 2006;58: In Italian Jay D. Coffman, Dennis L. Clement, Mark A. Creager, John A. Dormandy, Monique M.-L. Janssens, Robert J.R. McKendry, Gordon D. Murray, Steen L. Nielsen, International study of ketanserin in Raynaud's phenomenon, The American Journal of Medicine, Volume 87, Issue 3, September 1989, Pages , ISSN , DOI: /S (89) Legendre C, Allanore Y, Ferrand I, Kahan A. Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 2005;72: Leslie J. Heinberg, Ian Kudel, Barbara White, Amy Kwan, Keya Medley, Fredrick Wigley, Jennifer Haythornthwaite, Assessing body image in patients with systemic sclerosis (scleroderma): Validation of the Adapted Satisfaction with Appearance Scale, Body Image, Volume 4, Issue 1, March 2007, Pages 79-86, ISSN , DOI: /j.bodyim Kathy E. Linton, Richard G. Marriott, Self-esteem in adolescents: Validation of the state self-esteem scale, Personality and Individual Differences, Volume 21, Issue 1, July 1996, Pages 85-90, ISSN , DOI: / (96)83741-X. 10. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 2003;30: Mayes, M. D., Lacey, J. V. J., Beebe-Dimmer, J., Gillespie, B. W., Cooper, B., Laing, T. J., et al. (2003). Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population.. Arthritis Rheum, 48, Medsger, T. A. J. (1997). Systemic sclerosis (scleroderma): clinical aspects.. In W. J. Koopman (Ed.), Arthritis and Allied Conditions: A textbook of Rheumatology. Baltimore: Williams & Wilkins Malcarne, V.L. and Greenbergs, H.L., Psychological adjustment to systemic sclerosis. Arthritis Care Res 9, pp Merkel, P. A. (1998). Measurement of functional status, self-assessment, and psychological well-being in scleroderma. Current Opinion Rheumatology, 10, Rajnish A. Gupta, David Fiorentino, Localized scleroderma and systemic sclerosis: Is there a connection?, Best Practice & Research Clinical Rheumatology, Volume 21, Issue 6, Connective Tissue Diseases, December 2007, Pages , ISSN , Richards, H. L., Herrick, A. L., Griffin, K., Gwilliam, D. H., Loukes, J., & Fortune, D. G. (2003). Systemic Sclerosis: Patients' perceptions of their condition. Arthritis & Rheumatism (Arthritis Care & Research), 49(5), van Lankveld WG, Vonk MC, Teunissen H, van den Hoogen FH. Appearance self-esteem in systemic sclerosis subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology. 2007;46:872 6.